Table 1.
Patient Characteristics
| Characteristic | N(%) |
|---|---|
| Age(years) | |
| ≤60 | 47(57.3) |
| >60 | 35(42.7) |
| Sex | |
| Male | 71(86.6) |
| Female | 11(13.4) |
| T stage | |
| T2+T3 | 53(64.6) |
| T4 | 28(34.1) |
| Unknown | 1(1.3) |
| Lymph node metastasis | |
| Negative | 12(14.6) |
| Positive | 69(84.1) |
| Unknown | 1(1.3) |
| Primary tumour location | |
| Upper thoracic | 21(25.6) |
| Middle thoracic, lower thoracic | 61(64.4) |
| Smoking | |
| Yes | 30(36.6) |
| No | 52(63.4) |
| Alcohol consumption | |
| Yes | 71(86.6) |
| No | 11(13.4) |
| Primary tumour length | |
| ≤7 cm | 46(56.1) |
| >7 cm | 35(42.6) |
| Unknown | 1(1.3) |
| Chemoradiotherapy | |
| Yes | 71(86.6) |
| No | 11(13.4) |
| Chemotherapeutic regimens | |
| Paclitaxel concomitant with nedaplatin | 39(47.6) |
| Paclitaxel concomitant with cisplatin | 9(10.9) |
| Paclitaxel concomitant with carboplatin | 19(23.2) |
| 5-fluorouracil combined with cisplatin | 4(4.9) |
| No | 11(13.4) |
| Radiotherapy mode | |
| IMRT | 36(43.9) |
| 2DRT | 46(56.1) |
| Completed the operation as scheduled | |
| Yes | 60(73.2) |
| No | 22(26.8) |
| Operative method | |
| Esophageal cancer three-field radical surgery | 58(70.7) |
| Esophageal cancer two-field radical surgery | 2(2.5) |
| No | 22(26.8) |
| NLR | |
| ≤3.525 | 65(79.3) |
| >3.525 | 17(20.7) |
| PLR | |
| ≤209.6 | 68(82.9) |
| >209.6 | 14(17.1) |
| SII | |
| ≤916.6 | 62(75.6) |
| >916.6 | 20(24.4) |
| PNI | |
| ≤45.25 | 21(25.6) |
| >45.25 | 61(74.4) |
Abbreviations: IMRT, intensity-modulated radiotherapy; 2DRT, two-dimensional radiotherapy; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; SII, systemic immune-inflammation index; PNI, prognostic nutritional index.